Denise N. Bronner, Ph.D. is a microbiologist and immunologist whose scientific roots span the University of Michigan, where she earned her doctorate, and UC Davis, where her postdoctoral research investigated how commensal Enterobacteriaceae shape susceptibility to Salmonella infection work published in Nature Microbiology and Cell Host & Microbe. Her foundational training in host-pathogen interactions and microbial ecology gives her a distinct lens on the broader life sciences ecosystem.
After completing her postdoc, Denise made a deliberate pivot from the bench to industry and strategy. She joined Johnson & Johnson as a Director, leading global commercial efforts and cross-functional teams including work supporting the VISIBLE trial, published in JAMA Dermatology. She later founded Empactful Ventures, a boutique advisory firm at the intersection of pharma commercial strategy, clinical trial innovation, and patient advocacy, where she secured $20M+ in capital and contracts.
She has delivered 70+ speaking engagements across industry, academia, and advocacy, and mentors emerging scientists through Charles R. Drew University's BIP Accelerator and TechStars. Denise believes her most powerful credential is knowing what it means to be a scientist first and she brings that perspective to every room she enters, especially those filled with scientists figuring out what's next.